COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,688 Articles (22,478 medRxiv, 8,210 bioRxiv)

Most recent first Previous |  Page 2065: Articles 20641-20650  | Next

A multiagent coronavirus model with territorial vulnerability parameters
Magalhaes, P., Pinto, J. P. G., Segura-Angel, D. M.
10.1101/2020.10.25.20218735 — Posted: 2020-10-28
Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020
Hodcroft, E. B., Zuber, M., Nadeau, S., Comas, I., Gonzalez Candelas, F., SeqCOVID-SPAIN consortium, , Stadler, T., Neher, R. A.
10.1101/2020.10.25.20219063 — Posted: 2020-10-28 Discussion: Onsite
Optimal COVID-19 quarantine and testing strategies
Wells, C. R., Townsend, J. P., Pandey, A., Krieger, G., Singer, B. H., McDonald, R. H., Moghadas, S. M., Galvani, A. P.
10.1101/2020.10.27.20211631 — Posted: 2020-10-28 Discussion: Offsite
High-throughput fluorescent assay for inhibitor screening of proteases from RNA viruses
Cihlova, B., Huskova, A., Böserle, J., Nencka, R., Boura, E., Silhan, J.
10.1101/2020.10.27.357418 — Posted: 2020-10-28
Evaluation of a Modified Early Warning Score (MEWS) adjusted for COVID-19 patients (CEWS) to identify risk of ICU admission or death.
Smid, L., Osman, L., Arend, S. M., de Groot, S., de Boer, M. G. J.
10.1101/2020.10.22.20217539 — Posted: 2020-10-28
ACE2 Netlas: In-silico functional characterization and drug-gene interactions of ACE2 gene network to understand its potential involvement in COVID-19 susceptibility
Pathak, G. A., Wendt, F., Goswami, A., De Angelis, F., COVID-19 Host Genetics Initiative, , Polimanti, R.
10.1101/2020.10.27.20220665 — Posted: 2020-10-28
Performance of At-Home Self-Collected Saliva and Nasal-Oropharyngeal Swabs in the Surveillance of COVID-19
Braz-Silva, P. H., MAMANA, A. C., ROMANO, C. M., Felix, A. C., de Paula, A. V., Ferreira, N. E., Buss, L. F., Tozetto-Mendoza, T. R., Caixeta, R. A. V., Leal, F. E., Grespan, R. M. Z., Bizario, J. C. d. S., Ferraz, A. d. B. C., Sapkota, D., Giannecchini, S., To, K. K.-W., Doglio, A., Mendes-Correa, M. C.
10.1101/2020.10.23.20218487 — Posted: 2020-10-27
A booster dose enhances immunogenicity of the COVID-19 vaccine candidate ChAdOx1 nCoV-19 in aged mice
Silva-Cayetano, A., Foster, W. S., Innocentin, S., Belij-Rammerstorfer, S., Spencer, A. J., Burton, O. T., Fra-Bido, S., Lee, J. L., Thakur, N., Conceicao, C., Wright, D., Barrett, J., Evans-Bailey, N., Noble, C., Bailey, D., Liston, A., Gilbert, S. C., Lambe, T., Linterman, M. A.
10.1101/2020.10.27.357426 — Posted: 2020-10-27
Binding Mode of SARS-CoV2 Fusion Peptide to Human Cellular Membrane
Gorgun, D., Lihan, M., Kapoor, K., Tajkhorshid, E.
10.1101/2020.10.27.357350 — Posted: 2020-10-27
Genetic determinants of COVID-19 drug efficacy revealed by genome-wide CRISPR screens
Jiang, W., Yang, A., Ma, J., Lv, D., Liu, M., Xu, L., Wang, C., He, Z., Chen, S., Zhao, J., Chen, S., Jiang, Q., Chu, Y., Shan, L., Zhou, Z., Zhao, Y., Long, G., Jiang, H.
10.1101/2020.10.26.356279 — Posted: 2020-10-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).